Prevalence of HIV-I/II, HCV, HBsAg& Syphilis in Blood Donors Of Western Region In India
Prevalence of TTI in Blood Donors
DOI:
https://doi.org/10.70284/njirm.v7i1.1035Keywords:
Prevalence of TTI , Blood Donors, comprehensive screening of donorsAbstract
Background & Objective: The high prevalence of HIV, HBV, HCV and syphilis has heightened the problems of blood safety in India. TTIs cause fatal, chronic and life-threatening disorders because of their prolonged viraemia and carrier or latent state. Serologic tests utilized routinely in the screening of blood donors, totally not guarantee the absence of these infections among blood donors. Methodology: Samples of HIV, HBsAg, HCV were tested by ELISA and samples of syphilis were tested by RPR method following manufacturer’s instructions. Results: Prevalence of HBV was highest within at the age groups 26-35 years, HCV within the age group between 36-45years, syphilis within the age group between 46-55 years and HIV between 26-35 years. The prevalence of hepatitis B and syphilis was higher among males as compared to females, while for hepatitis C and HIV, it was higher among females as compared to males. Conclusion: Availability of safe blood for transfusion can be achieved by vigorous screening of donors and donated blood. Screening of blood is now mandatory for many diseases and is undertaken routinely in blood banks. The prevalence of TTIs among the Indian blood donors is reported to be ranging as follows; HBV – 0.66% to 12%, HCV – 0.5% to 1.5%, HIV– 0.084% to 3.87%, and syphilis – 0.85% to 3% respectively. Hence strict selection of blood donors with stringent screening and safe methods of detection can minimise risk if TTI. [Shah M NJIRM 2016; 7(1):12-15]
References
2. UNAIDS. Report on the global AIDS epidemic. Geneva, Joint United Nations program on HIV/AIDS; 2002.
3. Fasola FA, Otegbayo IA. Post-transfusion hepatitis in sickle cell anaemia; retrospective-prospective analysis. Nig J ClinPract. 2002;5:16–19.
4. Drosten C, Nippraschk T, Manegold C, Meisel H, Brixner V, Roth WK, Apedjinov A, Gunther S. Prevalence of Hepatitis B virus DNA in anti-HBCpositive/HBsAg- negative sera correlates with HCV but not HIV serostatus. J ClinVirol. 2004;29:59–68. doi: 10.1016/S1386-6532(03)00090-8.
5. Finlayson MDC, Hayes PC, Simpson KJ. In: Davidson's principles and practice of medicine.Haslett C, Chilvers ER, Hunter JAA, editor. Churchill Living stone, London; 1999. Diseases of the liver and biliary system: Hepatitis; pp. 706–715.
6. Murray P, Rosenthal K, Kobayashi G, Pfaller M. Medical Microbiology. 4. Mosby company, St.Loius; 2002. pp. 379–380.
7. Klein HG. Allogenic transfusion risk in the surgical patients. AMJ surg. 1995;170:21–26. doi: 10.1016/S0002-9610(99)80054-3.8. Mujeeb SA, Kausar A, Khalid M. Seroprevalence of HBV, HCV, and HIV infection among college going voluntary donors. J Pak Med Assoc. 2000;50:269–70.
9. Kar HK. Global and National overview of HIV/AIDS epidemic. In: Sharma VK, editor. Sexually transmitted diseases and HIV/AIDS. 2nd ed. New Delhi: Viva Books Pvt. Ltd; 2009. pp. 99–109
10. Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol. 2002;21:183–4.
11. Mollah AH, Nahar N, Siddique MA, Anwar KS, Hassan T, Azam MG. Common transfusion-transmitted infectious agents among thalassaemic children in Bangladesh. J Health PopulNutr. 2003;21:67–71.
12. Chattoraj A, Bhel R, Kataria V. Infectious disease markers in blood donors. Med J Armed Forces India.2008;64(1):33–5.
13. Kaur H, Dhanon J, Pawar G. Hepatitis C infection amongst blood donors in Punjab – a six year study.Indian J Hematol Blood Transfus. 2001;19:21–2.
14. Singh B, Verma M, Verma K. Markers of transfusion associated hepatitis in North Indian blood donors: Prevalence and trends. Jpn J Infect Dis. 2004;57:49–51.
15. Gupta N, Vijay Kumar, Kaur A. Seroprevalence of HIV, HBV, HCV, and Syphilis in voluntary blood donors. Indian J Med Sci. 2004;58:255–7.
16. Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBsAg, HCV and syphilis in replacement and voluntary blood donors in Western India. Indian J PatholMicrobiol. 2001;44:409–12.
17. Mumtaz S, Rehman MU, Muzaffar M, Hassan MU, Iqbal W. Frequency of seropositive blood donors for hepatitis B, C and HIV viruses in railway hospital, Rawalpindi. Pak J Med Res. 2002;41(2):19–2.
18. Dessie A, Abera B, FissehawaleSeroprevalence of major blood borne infections among blood donors at FelegeHiwot referral hospital, Northwest Ethopia. Ethiop J Health Dev. 2007;21:68–9.
19. Bagga PK, Singh SP. Seroprevalence of hepatitis C antibodies in healthy blood donors-a prospective study. Indian J PatholMicrobiol. 2007;50:429–32.
20. Jain A, Rana SS, Chakravarty P, Gupta RK, Murthy NS, Nath MC, et al. The prevalence of hepatitis C virus antibodies among voluntary blood donors of New Delhi, India. Eur J Epidemiol. 2003;18:695–7.
21. Sood G, Chauhan A, Sehgal S, Agnihotri S, Dilawari JB. Antibodies to hepatitis C virus in blood donors. Indian J Gastroenterol. 1992;11:44.
22. Tiwari B, Ghimire P, Karkee S, Rajkarnikar M. Seroprevalence of human immunodeficiency Virus in Nepalese blood donors: A study from three regional blood transfusion services. Asian J Transf Sci.2008;2:66–8.
23. Karkee S, Ghimire P, Tiwari B, Shrestha A. Seroprevalence of HIV and Hepatitis C coinfection among blood donors in Katmando valley, Nepal. Southeast Asian J Trop Med Public Health. 2009;40(1):66–70.
24. Matee M, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, Hepatitis B and C viruses and Syphilis infections among blood donors at the Muhimbiili National Hospital in Dar es Salam, Tanzania. BMC Public Health. 2006;6:21.
